(Q33463091)

27 July 2017

title

The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function (English)

1 reference

hemolytic-uremic syndrome

27 July 2017

main subject

1 reference

C. A. Thorsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A433976

1 July 2022

E. C. Rossi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A433976

1 July 2022

D. Green

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A433976

1 July 2022

F. A. Carone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A433976

1 July 2022

language of work or name

English

0 references

publication date

1 April 1979

1 reference

full work available at URL

27 July 2017

https://api.elsevier.com/content/article/PII:0002934379911902?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

https://api.elsevier.com/content/article/PII:0002934379911902?httpAccept=text/plain

7 May 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

American Journal of Medicine

7 May 2023

published in

1 reference

27 July 2017

volume

66

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

711-716

1 reference

The Hemolytic-Uremic Syndrome Is a Syndrome

27 July 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Heparin therapy in the haemolytic-uraemic syndrome

7 May 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Haemolytic-uraemic syndrome and heparin therapy

7 May 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Hemolytic-uraemic syndrome

7 May 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Fibrinolytic treatment of the haemolytic-uraemic syndrome

7 May 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Role of heparin therapy in the outcome of adult hemolytic uremic syndrome

7 May 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts)

7 May 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Platelet-inhibiting drugs iee parts)

7 May 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts)

7 May 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve Replacement

7 May 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Controlled trial of aspirin in cerebral ischemia

7 May 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial

7 May 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction

7 May 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Effect of dipyridamole and aspirin in thrombotic microangiopathy

7 May 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Thrombotic thrombocytopenic purpura. Survival following treatment with aspirin, dipyridamole, and prednisone

7 May 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Thrombotic thrombocytopenic purpura in a previously splenectomized patient

7 May 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Antiplatelet Treatment of Thrombotic Thrombocytopenic Purpura

7 May 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Are agents affecting platelet functions clinically useful?

7 May 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants

7 May 2023

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Streptokinase and anti-thrombotic therapy in the hemolytic-uremic syndrome

7 May 2023

24

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Haemolytic uraemic syndrome in women taking oral contraceptives

7 May 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

The haemolytic uraemic syndrome in adults

7 May 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

Thrombolytic Therapy in Haemolytic-Uraemic Syndrome

7 May 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(79)91190-2

7 May 2023

Identifiers

1 reference

27 July 2017

1 reference